Drug Name: Leqembi
Indications: To treat Alzheimer’s disease
Active Ingredient: Lecanemab-irmb
Company: Eisai Inc
Approval Date: 1/6/2023
More Details: https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761269Orig1s000lbl.pdf
Drug Name: Leqembi
Indications: To treat Alzheimer’s disease
Active Ingredient: Lecanemab-irmb
Company: Eisai Inc
Approval Date: 1/6/2023
More Details: https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761269Orig1s000lbl.pdf